Stocks
Revvity, Inc.

Revvity, Inc.RVTY

NYSEHealthcareDiagnostics & Research$124.06+0.96%

Price as of · delayed, not real-time

Formerly known as PerkinElmer, Revvity is a provider of life sciences and diagnostics solutions, offering analytical instruments, reagents, and software to research and clinical markets. The company is tracked by investors for its exposure to high-growth areas like genomics, diagnostics, and drug discovery tools.

Market Cap: $9.7B52W Range: $81.22-$133.00

Congressional Interest in Revvity, Inc. (RVTY)

7 members of Congress have disclosed 35 trades in Revvity, Inc. (RVTY), a Healthcare company. The buy/sell breakdown shows 19 purchases versus 16 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
35
Unique Politicians
7
Buys
19
Sells
16

Who in Congress Is Trading RVTY?

2026-06-30$1K-$15K
Stock
2026-05-15$1K-$15K
Stock
2026-05-04$15K-$50K
Stock
2026-05-01$1K-$15K
Stock
2026-04-13$1K-$15K
Stock
2026-02-05$1K-$15K
Stock
2026-01-29$1K-$15K
Stock
2025-09-12$1K-$15K
Stock
2025-08-13$1K-$15K
Stock
2025-07-23$1K-$15K
Stock
2025-07-22$1K-$15K
Stock
2025-06-17$1K-$15K
Stock
2025-06-11$1K-$15K
Stock
2025-05-28$1K-$15K
Stock
2025-05-28$1K-$15K
Stock
2025-04-23$1K-$15K
Stock
2025-04-08$1K-$15K
Stock
2025-03-06$1K-$15K
Stock
2025-02-28$15K-$50K
Stock
2025-02-25$1K-$15K
Stock
2025-02-19$1K-$15K
Stock
2024-11-15$1K-$15K
Stock
2024-05-05$1K-$15K
Stock
2024-04-25$1K-$15K
Stock
2023-11-03$1K-$15K
Stock
2023-10-02$1K-$15K
Stock
2023-06-26$1K-$15K
Stock
2022-11-03$1K-$15K
Stock
2022-05-09$1K-$15K
Stock
2018-12-04$1K-$15K
Stock
2018-06-21$1K-$15K
Stock
2018-05-02$1K-$15K
Stock
2018-02-06$1K-$15K
Stock
2017-08-02$1K-$15K
Stock
2017-06-20$15K-$50K
Stock